RNT Stock Overview
Private Rented Sector S.A. develops and commercializes medical isotopes in Poland.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Private Rented Sector S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | zł6.50 |
52 Week High | zł11.60 |
52 Week Low | zł2.00 |
Beta | 2.36 |
1 Month Change | 22.64% |
3 Month Change | 198.17% |
1 Year Change | -19.75% |
3 Year Change | 212.50% |
5 Year Change | 475.22% |
Change since IPO | -96.31% |
Recent News & Updates
Recent updates
Shareholder Returns
RNT | PL Medical Equipment | PL Market | |
---|---|---|---|
7D | 0% | -0.8% | -0.02% |
1Y | -19.8% | -11.4% | 25.7% |
Return vs Industry: RNT underperformed the Polish Medical Equipment industry which returned -11.4% over the past year.
Return vs Market: RNT underperformed the Polish Market which returned 25.7% over the past year.
Price Volatility
RNT volatility | |
---|---|
RNT Average Weekly Movement | 34.5% |
Medical Equipment Industry Average Movement | 4.4% |
Market Average Movement | 5.2% |
10% most volatile stocks in PL Market | 9.8% |
10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: RNT's share price has been volatile over the past 3 months.
Volatility Over Time: RNT's weekly volatility has increased from 23% to 34% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Jakuba Suchanek | www.medical-isotope.com |
Private Rented Sector S.A. develops and commercializes medical isotopes in Poland. The company offers Technetium-99m, a medical isotope for deployment using standard research and commercial reactors. The company was formerly known as Perma-Fix Medical S.A. and changed its name to Private Rented Sector S.A. in March 2023.
Private Rented Sector S.A. Fundamentals Summary
RNT fundamental statistics | |
---|---|
Market cap | zł8.59m |
Earnings (TTM) | zł27.21k |
Revenue (TTM) | zł200.00k |
315.7x
P/E Ratio42.9x
P/S RatioIs RNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RNT income statement (TTM) | |
---|---|
Revenue | zł200.00k |
Cost of Revenue | zł0 |
Gross Profit | zł200.00k |
Other Expenses | zł172.80k |
Earnings | zł27.21k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
Earnings per share (EPS) | 0.021 |
Gross Margin | 100.00% |
Net Profit Margin | 13.60% |
Debt/Equity Ratio | 0% |
How did RNT perform over the long term?
See historical performance and comparison